sulfinpyrazone has been researched along with Leukemia, Basophilic, Acute in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millard, PJ | 1 |
| Ryan, TA | 1 |
| Webb, WW | 1 |
| Fewtrell, C | 1 |
1 other study available for sulfinpyrazone and Leukemia, Basophilic, Acute
| Article | Year |
|---|---|
Immunoglobulin E receptor cross-linking induces oscillations in intracellular free ionized calcium in individual tumor mast cells.
Topics: Adenosine Triphosphate; Animals; Antigens, Differentiation, B-Lymphocyte; Benzofurans; Calcium; Cell | 1989 |